Latest news
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder - Medical DailyMedical Daily · Fri, 07 Aug 2026 10:30:02 GMTTakeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 09:53:37 GMTFDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1 - Patient Care OnlinePatient Care Online · Fri, 07 Aug 2026 06:16:23 GMTNew Narcolepsy Drug Signals a Shift From Symptom Management to Disease-Based Treatment - Medical DailyMedical Daily · Fri, 07 Aug 2026 01:30:22 GMTFDA approves first drug for full range of narcolepsy symptoms - Medical XpressMedical Xpress · Thu, 06 Aug 2026 22:00:03 GMTFDA Approves First-in-Class Narcolepsy Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 20:46:04 GMTFDA Approves Oveporexton for Adults With Narcolepsy Type 1 - HMP Global Learning NetworkHMP Global Learning Network · Thu, 06 Aug 2026 20:00:56 GMT